• Mutation; VGNC; VGNC:38196; ASXL1; Simple; p.Gly618fs (c.1850dupG); Zygosity=Heterozygous (PubMed=31175136).
  
• Mutation; VGNC; VGNC:40797; FBXW7; Simple; p.Arg694Gln (c.2081G>A); Zygosity=Heterozygous (PubMed=31175136).
  
• Mutation; VGNC; VGNC:42490; KMT2C; Simple; p.Gly976fs (c.2922delG); Zygosity=Heterozygous (PubMed=31175136).
  
• Mutation; VGNC; VGNC:42491; KMT2D; Simple; p.Gln5395fs (c.16183delC); Zygosity=Homozygous (PubMed=31175136).
  
• Mutation; VGNC; VGNC:43761; NF1; Simple; p.Asn58fs (c.167delA); Zygosity=Homozygous (PubMed=31175136).
  
• Mutation; VGNC; VGNC:44567; PTEN; Simple; p.Lys245fs (c.734delA); Zygosity=Homozygous (PubMed=31175136).
  
• Mutation; VGNC; VGNC:112756; SPEN; Simple; p.Ala8fs (c.13_14insG); Zygosity=Heterozygous (PubMed=31175136).
  
• Mutation; VGNC; VGNC:47719; TP53; Simple; p.Arg164His (c.491G>A); Zygosity=Heterozygous (PubMed=31175136).
  

PubMed=17532464; DOI=10.1016/j.leukres.2007.04.003
William C. Kisseberth, Murali Vara Prasad Nadella, Matthew Breen, Rachael Thomas, Shannon E. Duke, Sridhar Murahari, Carrie E. Kosarek, William Vernau, Anne C. Avery, Mary Jo Burkhard, Thomas John Rosol;
A novel canine lymphoma cell line: a translational and comparative model for lymphoma research.
Leuk. Res. 31:1709-1720(2007)

Patent=US7897150
William C. Kisseberth;
Canine lymphoma cell line and uses thereof.
Patent number US7897150, 01-Mar-2011

PubMed=21908323; DOI=10.1177/1040638711408064
Liza E. O'Donoghue, Jason P. Rivest, Dawn L. Duval;
Polymerase chain reaction-based species verification and microsatellite analysis for canine cell line validation.
J. Vet. Diagn. Invest. 23:780-785(2011)

PubMed=23365669; DOI=10.1371/journal.pone.0054464; PMCID=PMC3554772
James W. Wells, Christopher H. Evans, Milcah C. Scott, Barbara C. Rutgen, Timothy D. O'Brien, Jaime F. Modiano, Goran Cvetkovic, Slobodan Tepic;
Arginase treatment prevents the recovery of canine lymphoma and osteosarcoma cells resistant to the toxic effects of prolonged arginine deprivation.
PLoS ONE 8:e54464.1-e54464.9(2013)

PubMed=27257868; DOI=10.1371/journal.pone.0156689; PMCID=PMC4892608
Junko Maeda, Coral Eva Froning, Colleen A. Brents, Barbara J. Rose, Douglas H. Thamm, Takamitsu A. Kato;
Intrinsic radiosensitivity and cellular characterization of 27 canine cancer cell lines.
PLoS ONE 11:e0156689.1-e0156689.18(2016)

PubMed=26842912; DOI=10.1111/vco.12197
Genevieve Hartley, Erica Ann Faulhaber, Alison Caldwell, Jonathan Coy, Jade N. Kurihara, Amanda Guth, Daniel P. Regan, Steven W. Dow;
Immune regulation of canine tumour and macrophage PD-L1 expression.
Vet. Comp. Oncol. 15:534-549(2017)

PubMed=27197945; DOI=10.1111/vco.12192; PMCID=PMC5656225
Jared S. Fowles, Deanna D. Dailey, Daniel L. Gustafson, Douglas H. Thamm, Dawn L. Duval;
The Flint Animal Cancer Center (FACC) canine tumour cell line panel: a resource for veterinary drug discovery, comparative oncology and translational medicine.
Vet. Comp. Oncol. 15:481-492(2017)

PubMed=29674676; DOI=10.1038/s41598-018-23207-7; PMCID=PMC5908872
Leila Taher, Julia Beck, Wen Liu, Catrin Roolf, Jan T. Soller, Barbara C. Rutgen, Sabine E. Hammer, Murali Chodisetti, Sina Sender, Katharina Anna Sterenczak, Georg Fuellen ...Show all 16 authors... , Christian Junghanss, Bertram Brenig, Ingo Nolte, Ekkehard Schutz, Hugo Murua Escobar; Show fewer authors
Comparative high-resolution transcriptome sequencing of lymphoma cell lines and de novo lymphomas reveals cell-line-specific pathway dysregulation.
Sci. Rep. 8:6279.1-6279.12(2018)

PubMed=31175136; DOI=10.1158/1535-7163.MCT-18-1346; PMCID=PMC6679748
Sunetra Das, Rupa Idate, Kathryn E. Cronise, Daniel L. Gustafson, Dawn L. Duval;
Identifying candidate druggable targets in canine cancer cell lines using whole-exome sequencing.
Mol. Cancer Ther. 18:1460-1471(2019)